A metagene of NRF2 expression is a prognostic biomarker in all stage colorectal cancer (2019)
Attributed to:
Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/690974
Publication URI: http://dx.doi.org/10.1101/690974
Type: Preprint